Jim Simons's position in Acorda Therapeutics is currently worth $30.2 Thousand. That's 0.00% of their equity portfolio (3232nd largest holding). The investor owns Inf% of the outstanding Acorda Therapeutics stock. The first Acorda Therapeutics trade was made in Q4 2013. Since then Jim Simons bought shares twenty more times and sold shares on seventeen occasions. The investor's estimated purchase price is $3.17 Million, resulting in a loss of 99%.